Despite the high incidence of brain metastasis after resection of non-small cell lung cancer (NSCLC), the National Comprehensive Cancer Network guidelines do not recommend central nervous system (CNS) ...

LONDON (AP) — King Charles III smiled and waved to members of the public Friday as he left his home in London, the day after ...

As AstraZeneca awaits an FDA decision for its Daiichi Sankyo-partnered Datroway in EGFR-mutated non-small cell lung cancer ...

SAVANNAH Phase II trial demonstrated high and durable response rates with savolitinib plus TAGRISSO® in MET-high lung cancer, representing a ...

Targeted therapies have significantly improved outcomes for patients with non-small cell lung cancer (NSCLC) with actionable mutations. However, many tumors inevitably develop drug resistance and ...

The first-line combination of amivantamab-vmjw plus lazertinib extended OS compared with osimertinib for patients with EGFR-mutated advanced non-small cell lung cancer, according to data from the ...

The hospital says it’s the first in the Central Valley to use the Ion system and is part of the next wave of health care for lung cancer. More conventional methods of diagnosing the disease ...

Leaves are mainly consumed in the Pacific Ocean, Africa, Asia, China, Taiwan, the Caribbean, and Southern and Central America ... of human breast and lung cancer cells. The extracts worked ...

Discover how high-sugar diets contribute to more aggressive lung tumor growth - and how this knowledge could shape future cancer treatments.

ABSTRACT #207P: Phase 1 Study of Reirradiation (“ReRT”) with NBTXR3 (JNJ-1900) for Inoperable Locoregional Recurrent Non-Small Cell Lung Cancer (“NSCLC”) Saumil ... disorders of the central nervous ...

About NSCLC and SAVANNAH Lung cancer is the leading cause of cancer death among men and women, accounting for about one-fifth of all cancer deaths. Lung cancer is broadly split into SCLC or NSCLC ...